InvestorsHub Logo

stingman49

09/05/20 4:24 PM

#24745 RE: fantomphan #24742

Why do you keep saying that Q3 will be bad??

2020 Third Quarter Revenue Guidance

CytoSorbents has not historically given specific financial guidance on quarterly results until the quarter has been completed. However, notwithstanding uncertainty related to the COVID-19 pandemic, based upon current order patterns, we expect that Q3 2020 will be one of the company's strongest quarters to date in terms of product sales.

You keep saying it enough times people will just start taking for granted.

Burnttoast247

09/06/20 9:57 AM

#24747 RE: fantomphan #24742

YOU DON’T need the added cost, but if your the two guys getting paid I’m sure they can give you a long list to justify themselves! IMO this company should have placed 95% of their available resources in GERMANY and surrounding EU COUNTRIES then selectively added countries that would fast track that successful model. But we are where we are stumbling along with a great product. Hoping some company sees what many of us see and gobbles up this GEM

hemopure36

09/06/20 1:12 PM

#24748 RE: fantomphan #24742

As usual, you misunderstood (distorted?) what I'm saying. I think the unrealistic part is to assume no FDA Ticagrelor trial as your baseline case. Until one astute poster here pointed out that Dr. Chan said, "...if..." we need a trial, everyone assumed, and by all odds rightly so, that we would be required to conduct one. And we even discussed here that the good news is that the trial would likely be easy and relatively fast. But because Dr. Chan uttered the word, "if," you now try to make people think that if we're required to to a study, it's part of a "we're screwed" scenario, which is very disingenuous, at best. Aside from that, separate and distinct, I think it's a high hill to climb to demonstrate a statistically significant mortality benefit among the REMOVE study cohort. I'm not saying it's impossible, but I think it's rather unlikely. Nonetheless, I do believe that overall, the study will be a success on other endpoints, but I'm sure you will spin it as disastrous, regardless of the outcome. I don't know how you can routinely spin normal, baseline and even good news into an abyss of negativity. It's just astounding to me and I hope people who pass by here take it with a grain of salt. Good luck!